Form 4 for STEX Streamex Corp.
Accepted 2022-04-08 00:00:00 ET · period of report 2022-03-21 · accession 0001185185-22-000415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-08 | 2022-03-21 | STEX | Sieckhaus John | COO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| D | 2022-04-08 | 2022-03-30 | STEX | Sieckhaus John | COO | A - Grant | $0.00 | +350.0K | 350.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-21 | A | A | 50,000 | $0.00 | 50,000 | D | — | — | (F1) The reporting person received the shares as a one-time signing bonus upon the commencement of the reporting person's employment with the Company. |
| 2 | Derivative | Options | 2022-03-30 | A | A | 350,000 | $0.00 | 350,000 | D | $1.30 · — to 2032-03-30 | 350,000 Common Stock | (F2) The shares underlying this stock option will vest over three years, with 1/3 vesting on the first anniversary of March 30, 2022 and 2/3 vesting in substantially equal quarterly installments thereafter, subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan. |